Beneficial effects of antioxidant therapy in crush syndrome in a rodent model: enough evidences to be used in humans?

Ann Intensive Care. 2018 Sep 27;8(1):96. doi: 10.1186/s13613-018-0431-5.

Authors

Patrick M Honore¹, David De Bels², Herbert D Spapen³

Affiliations

¹ ICU Department, Centre Hospitalier Universitaire Brugmann, 4, Place Arthur Van Gehuchten, 1020, Brussels, Belgium. [email protected].
² ICU Department, Centre Hospitalier Universitaire Brugmann, 4, Place Arthur Van Gehuchten, 1020, Brussels, Belgium.
³ Universitair Ziekenhuis Brussel, VUB University, Brussels, Belgium.

No abstract available

Keywords: Antioxidant therapy; Astragaloside IV; Crush syndrome; Ischemia–reperfusion injury; Rhabdomyolysis.

Publication types

Editorial